Differential inhibition of rat tissue catalase by cyanamide. 1986

E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa

The relative sensitivity of rat tissue catalase to inhibition by intraperitoneally administered cyanamide was liver greater than kidney greater than heart greater than brain, whereas the activity of the erythrocyte enzyme was affected minimally. The measured ED50 values for cyanamide in these tissues were 31, 44, 107 and 680 mumoles/kg body weight for liver, kidney, heart and brain respectively. On a molar basis, cyanamide was approximately twenty times more potent than 3-amino-1,2,4-triazole (3-AT) in inhibiting hepatic catalase in vivo in the rat. Like 3-AT, cyanamide inhibited erythrocyte catalase activity in vitro in the presence of hydrogen peroxide. The apparent similarities between the inhibition of hepatic catalase by cyanamide and 3-AT in vivo suggest that cyanamide belongs to the family of 3-AT-like catalase inhibitors.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D003484 Cyanamide A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism. Calcium Carbimide,Calcium Cyanamide,Citrated Calcium Cyanamide,Abstem,Carbimide,Colme,Cyanamide, Calcium (1:1) Salt,Cyanamide, Calcium (2:1) Salt,Cyanamide, Calcium Salt,Temposil,Calcium Cyanamide, Citrated,Calcium Salt Cyanamide,Carbimide, Calcium,Cyanamide, Calcium,Cyanamide, Citrated Calcium
D003486 Cyanides Inorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical. Cyanide,Isocyanide,Isocyanides
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen

Related Publications

E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
September 1961, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
December 1985, Toxicology letters,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
October 1958, Biochimica et biophysica acta,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
August 1957, The Journal of biological chemistry,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
March 1972, FEBS letters,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
July 1989, Biochemical pharmacology,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
September 1983, Canadian journal of physiology and pharmacology,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
September 1969, Clinica chimica acta; international journal of clinical chemistry,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
April 1983, Canadian journal of physiology and pharmacology,
E G DeMaster, and B Redfern, and F N Shirota, and H T Nagasawa
December 1969, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!